Wnt signaling and cancer development: therapeutic implication.

Wnt signaling and cancer development: therapeutic implication. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Wnt signaling and cancer development: therapeutic implication. Abstract Text:

Wnt proteins are a large family of secreted glycoproteins that activate signal transduction pathways to control a wide variety of cellular processes such as determination of cell fate, proliferation, migration, and polarity. Wnts are capable of signaling through several pathways, the best-characterized being the canonical beta-catenin/Tcf-mediated pathway. Canonical Wnts stabilize beta-catenin protein, which has implications in the genesis of many human cancers like non-small cell lung cancer, colorectal carcinoma, prostate cancer, breast cancer and many others. In all of these cancers the common denominator is the activation of target genes. Although detailed mechanisms are not well understood of why Wnts are overexpressed in one tumor and down regulated in another, the pleiotropism of Wnt signaling is evident. The pathway itself offers ample targeting nodal points for cancer drug development. The identification of many important regulatory genes and the mechanism of their function offer an opportunity to develop new therapies targeting this pathway. In this review, we describe the roles of several oncogenes of the Wnt/beta-catenin signaling pathway in the development of tumorigenesis and discuss few strategies that are already developed or can be explored to target key components of the Wnt/ beta-catenin signaling pathway in finding of anti-cancer drugs. Key words: Wnt signaling, Oncogene, beta-Catenin, Neoplasm, Tumorigenesis, Colorectal cancer, Prostate cancer, Anti cancer drug.

Wnt signaling and cancer development: therapeutic implication. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Wnt signaling and cancer development: therapeutic implication. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Neoplasma

VOLUME: 55

Page Numbers: 165-76

Journal Abbreviation: Neoplasma

ISSN: 0028-2685

DAY: 19

MONTH: 03

YEAR: 2008

Wnt signaling and cancer development: therapeutic implication. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 377266

Wnt signaling and cancer development: therapeutic implication. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Wnt signaling and cancer development: therapeutic implication. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Wnt signaling and cancer development: therapeutic implication.

AFFILIATION:

Country: Slovakia

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Neoplasma

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Wnt signaling and cancer development: therapeutic implication Related Publications

• A program for simulated rodent surgical training.
• Aplasia cutis congenita.
• Arsenite resistance in leishmania and possible drug targets.
• Characterization of antimicrobial compounds produced by Pseudomonas aurantiaca S-1.
• Comparative evaluation of clindamycin phosphate 1% and clindamycin phosphate 1% with nicotinamide gel 4% in the treatment of acne vulgaris.
• Consumer health informatics: an overview of patient perspectives on health information needs.
• Deficiency of co-chaperone immunophilin FKBP52 compromises sperm fertilizing capacity.
• Dental services in Tripura (India).
• Dichloroacetate- and trichloroacetate-induced phagocytic activation and production of oxidative stress in the hepatic tissues of mice after acute exposure.
• Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
• Efficacy and tolerability of pegylated interferon alpha 2b and ribavirin in chronic hepatitis C--a report from eastern India.
• Electronic structure and total energy of SrBi(2)Ta(2 )O(9) by first-principles calculations.
• Exposure to blood-borne viruses among healthcare workers in a tertiary care hospital in south India.
• Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer.
• FKBP52 deficiency-conferred uterine progesterone resistance is genetic background and pregnancy stage specific.
• Fall injury episodes among noninstitutionalized older adults: United States, 2001-2003.
• Influence of overstory density on ecophysiology of red oak (Quercus rubra) and sugar maple (Acer saccharum) seedlings in central Ontario shelterwoods.
• Influence of space-charge on hysteresis loop characteristics of ferroelectric thin films.
• Markers of myocardial blood flow.
• Maternal heparin-binding-EGF deficiency limits pregnancy success in mice.
• Maternal pentraxin 3 deficiency compromises implantation in mice.
• Metal-thiolate bonds in bioinorganic chemistry.
• MicroRNA regulation of cyclooxygenase-2 during embryo implantation.
• Mixed valent sites in biological electron transfer.
• Progesterone receptor requires a co-chaperone for signalling in uterine biology and implantation.
• RNAi-mediated silencing of prohormone convertase (PC) 5/6 expression leads to impairment in processing of cocaine- and amphetamine-regulated transcript (CART) precursor.
• Ringworm of the glabrous skin, a statistical survey.
• Studies on ringworm; fungus diseases of the nails and the surrounding tissues.
• Transient expression, purification and characterization of bioactive human fibroblast growth factor 8b in tobacco plants.
• Wnt signaling and cancer development: therapeutic implication.